Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1977 Jun;60(2):319P.

Irreversible protein binding of [14C]-practolol metabolite(s) to hamster liver microsomes (proceedings).

T C Orton, C Lowery, W E Lindup
PMCID: PMC1667410  PMID: 880481

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amos H. E., Brigden W. D., McKerron R. A. Untoward effects associated with practolol: demonstration of antibody binding to epithelial tissue. Br Med J. 1975 Mar 15;1(5958):598–600. doi: 10.1136/bmj.1.5958.598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Behan P. O., Behan W. M., Zacharias F. J., Nicholls J. T. Immunological abnormalities in patients who had the oculomucocutaneous syndrome associated with practolol therapy. Lancet. 1976 Nov 6;2(7993):984–987. doi: 10.1016/s0140-6736(76)90831-x. [DOI] [PubMed] [Google Scholar]
  3. Potter W. Z., Davis D. C., Mitchell J. R., Jollow D. J., Gillette J. R., Brodie B. B. Acetaminophen-induced hepatic necrosis. 3. Cytochrome P-450-mediated covalent binding in vitro. J Pharmacol Exp Ther. 1973 Oct;187(1):203–210. [PubMed] [Google Scholar]
  4. Wall-Manning H. J. Problems with practolol. Drugs. 1975;10(5-6):336–341. doi: 10.2165/00003495-197510050-00003. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES